Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT06630598
Clinical Trial
Impacts of the VEGA Family Violence Education Resources for Psychology Trainees
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 26, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.
Summary
The current research project aims to assess the effectiveness of the ©Violence, Evidence, Guidance, and Action (VEGA) Family Violence Education Resources (VEGA Project, 2019) in improving the knowledge, self-efficacy, and clinical responses of clinical psychology doctoral students to family violence in clinical settings. The VEGA on-line training is a collection of family violence online education resources designed to inform health and social service practitioners about family violence in a Canadian context, including definitions of family violence, mandatory reporting duties, effective responding to survivors, and more. Participants in this trial will be doctoral students recruited from accredited Clinical Psychology programs across Canada. Participants will be assigned to an intervention or wait-list control group, and the outcome measures consist of knowledge and attitudes about family violence, as well as measures of skills relevant to appropriately responding to survivors in clinical settings. Further, participants will be invited to complete a qualitative interview after the intervention to discuss overall impressions of the training and other ways the training changed their perspectives, if at all, on family violence.
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-03.
Status change: Not Yet Recruiting → Recruiting
2024-11-23
Trial Details
NCT Number
NCT06630598
Lead Sponsor
University of Ottawa
Conditions
Family Violence
Enrollment
90 participants
Start Date
2024-10-30
Primary Completion
2025-03
(estimated)
Study Completion
2025-03
(estimated)
Updated on ClinicalTrials.gov
2024-11-26